BioLineRx (BLRX) Total Debt Growth (5y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.92% |
| Sep 30, 2025 | 9.09% |
| Jun 30, 2025 | 9.25% |
| Mar 31, 2025 | 9.42% |
| Dec 31, 2024 | 9.61% |
| Sep 30, 2024 | 24.82% |
| Jun 30, 2024 | 26.81% |
| Mar 31, 2024 | 1.65% |
| Dec 31, 2023 | 2.28% |
| Sep 30, 2023 | 166.39% |
| Jun 30, 2023 | 154.22% |
| Mar 31, 2023 | 140.93% |
| Dec 31, 2022 | 109.83% |
| Sep 30, 2022 | 119.42% |
| Jun 30, 2022 | 37.92% |
| Mar 31, 2022 | 53.00% |
| Dec 31, 2021 | 51.72% |
| Sep 30, 2021 | 67.39% |
| Jun 30, 2021 | 71.25% |
| Mar 31, 2021 | 74.05% |
| Dec 31, 2020 | 76.14% |
| Sep 30, 2020 | 77.91% |